Familial Cancer Syndrome Linked to Colorectal Cancer in Younger People

Important Factor in Limiting Risk of Additional Cancers in Patients and their Family Members

New York, January 28, 1999 -- Nearly one-fifth of patients who develop colorectal cancer at a young age (40 and younger) have a family history consistent with a familial colorectal cancer syndrome known as hereditary non-polyposis colorectal cancer (HNPCC), according to researchers at Memorial Sloan-Kettering Cancer Center.

The study, published in the current issue of Diseases of the Colon and Rectum, looked at 230 patients 40 years of age and younger who were diagnosed with colorectal cancer and found that nearly 20 percent of them had the HNPCC syndrome.

HNPCC is a dominantly inherited disorder, accounting for about five percent of all colorectal cancer cases. It is generally a fast-growing cancer that affects people primarily in their 40s. People who carry the genetic mutation for HNPCC have an 80 to 85 percent lifetime risk of developing colorectal cancer and are at increased risk of developing endometrial, ovarian, stomach, kidney, and other cancers. The criteria for a clinical diagnosis of HNPCC include: three first-degree relatives with colorectal cancer, spanning two generations, one of whom is less than 50 years of age at the time of diagnosis. This would exclude those with another type of inherited colorectal cancer called Familial Adenomatous Polyposis, a condition where people develop hundreds of colon polyps at a very young age.

"Individuals who develop colorectal cancer at a young age require special surveillance to protect them from developing other types of cancers," said Dr. Jose Guillem, Associate Attending Surgeon at Memorial Sloan-Kettering Cancer Center and lead author of the study. "By identifying and tracking individuals with HNPCC, we can intervene at an early stage and make appropriate, and where warranted, aggressive treatment decisions to prevent the development of additional colorectal and other cance

Contact: Stacey Harris
Memorial Sloan-Kettering Cancer Center

Page: 1 2

Related biology news :

1. Genetic, Familial Factors Influence ADHD, Not Necessarily Sex Of Child
2. Cancer vaccine based on pathogenic listeria bacteria shows promise targeting metastases
3. 16th EORTC NCI AACR Symposium Molecular Targets and Cancer Therapeutics
4. 16th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
5. Cancer gene MYC emerging as key research target
6. Cancer patient, heal thyself
7. USC researcher named General Motors Cancer Research Scholar
8. Fox Chase Cancer Centers Alfred Knudson Jr. named 2004 Kyoto Prize winner
9. Wilex & Fox Chase Cancer Center begin trial w/ novel compound targeting tumor invasion & metastasis
10. Cancer drug resistance research leads to possible therapeutic target for Alzheimers disease
11. Fox Chase Cancer Center research shows kidney cancer can be diagnosed in urine

Post Your Comments:

(Date:4/18/2020)... ... April 17, 2020 , ... ... device that uses magnetic nano-beads to isolate minute bacterial particles that cause ... bacterial infections and difficult-to-detect micro-particles such as those making up Ebola and ...
(Date:4/15/2020)... ... ... NDA Partners Chairman Carl Peck, MD , announced today that ... the Center for Drug Evaluation and Research and former Branch Chief of Radiation Programs ... firm as an Expert Consultant. , Dr. Suleiman has expertise in health physics, medical ...
(Date:4/14/2020)... ... April 14, 2020 , ... ... and webinars, continues to provide cutting-edge research and findings about the latest developments ... Week will feature more than 25 educational, scientific discussions, including 3 keynote ...
Breaking Biology News(10 mins):
(Date:5/21/2020)... ... ... Eaton Square is pleased to announce its growth on the East Coast of the ... and M&A advisory firm. , This is an important step for Eaton Square as ... innovators with capital and investors. , Popper and Company, founded in 2003 by Caroline ...
(Date:5/15/2020)... ... May 14, 2020 , ... ... working cell banks and hMSC bioprocess systems, today announced the launch of ... hMSC-derived extracellular vesicles (EVs). RoosterCollect™-EV-CC is the only system designed with hMSC-EV ...
(Date:5/15/2020)... ... , ... This new service offers clients a way to speak with Subject ... the need arises. Lachman’s OnCall SMEs have extensive knowledge of a wide range of ... OnCall™ SMEs are available normal business hours Monday through Friday from 9:00 am – ...
(Date:5/14/2020)... ... 2020 , ... DuPont Nutrition & Biosciences (N&B) has announced ... care ingredients in Russia and Belarus. Beginning May 1, Interdisp JCS will represent ... , The GENENCARE®OSMS product line contains a range of all-natural, 100 ...
Breaking Biology Technology:
Cached News: